News
The liver, often underappreciated, plays vital roles and faces unique challenges in women due to hormonal, metabolic, and ...
Recent study analyzed postoperative liver dysfunction following lung transplantation with extracorporeal life support and its ...
Fat-soluble vitamins (FSV) are also malabsorbed in cholestasis, and regular supplementation ... an ideal feed for infants with liver disease would be a palatable (whole protein) formula with ...
Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the first dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC).
GSK has reported promising results with a drug to treat the severe itching that plagues patients with rare cholestatic liver disease primary biliary cholangitis (PBC). Interim results from the ...
ProQR Therapeutics N.V.’s PRQR share price has dipped by 5.53%, which has investors questioning if this is right time to buy.
Giloy, a popular herb in Ayurvedic medicine, gained prominence during the COVID-19 pandemic for its immunity-boosting ...
White patients had an increased burden of advanced liver fibrosis vs Black patients, despite comparable levels of inflammation.
The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...
Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...
Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...
Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results